Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review

BACKGROUND: Historical restrictions on take-home medications for opioid use disorder have generated considerable debate. The COVID-19 pandemic shifted the perceived risks and benefits of daily clinic attendance and led to widespread policy reform, creating an unprecedented opportunity to explore the...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, Alison, Blawatt, Sarin, MacDonald, Scott, Finnick, Rhys, Lajeunesse, Julie, Harrison, Scott, Byres, David, Schechter, Martin T., Oviedo-Joekes, Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165059/
https://www.ncbi.nlm.nih.gov/pubmed/37182352
http://dx.doi.org/10.1016/j.drugpo.2023.104058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165059/
https://www.ncbi.nlm.nih.gov/pubmed/37182352
http://dx.doi.org/10.1016/j.drugpo.2023.104058

Ejemplares similares